Showing results (81-90 of 105) with videos related to

Sort By:
Pageof 11
Neurology and Therapy|February 8, 2024
Long-Term Effectiveness of Galcanezumab in the Prevention of Migraine: An Italian Retrospective Analysis (REALITY)Fabrizio Vernieri, Luigi Francesco Iannone, Simona Guerzoni, et al.
Pain Medicine (Malden, Mass.)|January 28, 2016
Prevalence and Time Course of Post-Stroke Pain: A Multicenter Prospective Hospital-Based StudyStefano Paolucci, Marco Iosa, Danilo Toni, et al.
Nutrients|August 10, 2021
Applications of Ketogenic Diets in Patients with Headache: Clinical RecommendationsCherubino Di Lorenzo, Giovanna Ballerini, Piero Barbanti, et al.
Journal of Neurology|January 25, 2025
Three-year treatment with anti-CGRP monoclonal antibodies modifies migraine course: the prospective, multicenter I-GRAINE studyPiero Barbanti, Cinzia Aurilia, Paola Torelli, et al.
Neurological Sciences : Official Journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology|May 18, 2026
Building bridges in migraine management: consensus pathways on best practices across primary and specialist care in ItalyPiero Barbanti, Cristina Tassorelli, Fabrizio Vernieri, et al.
European Journal of Neurology|September 25, 2024
Sumatriptan-naproxen sodium in migraine: A reviewRobyn-Jenia Wilcha, Shazia K Afridi, Piero Barbanti, et al.
Neurology and Therapy|December 18, 2025
Moderate to Severe Acute Migraine Attacks: An Opinion Paper on the Use of Triptans and Triptan-NSAIDs Combinations in Individualized Treatment PlansPeter J Goadsby, Alexandra J Sinclair, Shazia K Afridi, et al.
European Journal of Neurology|September 13, 2022
Maintenance of response and predictive factors of 1-year GalcanezumAb treatment in real-life migraine patients in Italy: The multicenter prospective cohort GARLIT studyFabrizio Vernieri, Nicoletta Brunelli, Marilena Marcosano, et al.
The Journal of Headache and Pain|September 12, 2018
Validation of a self-reported instrument to assess work-related difficulties in patients with migraine: the HEADWORK questionnaireAlberto Raggi, Venusia Covelli, Erika Guastafierro, et al.
The Journal of Headache and Pain|November 1, 2022
Predictors of response to anti-CGRP monoclonal antibodies: a 24-week, multicenter, prospective study on 864 migraine patientsPiero Barbanti, Gabriella Egeo, Cinzia Aurilia, et al.
Pageof 11